0001710388-17-000001.txt : 20170628 0001710388-17-000001.hdr.sgml : 20170628 20170627181611 ACCESSION NUMBER: 0001710388-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170628 DATE AS OF CHANGE: 20170627 EFFECTIVENESS DATE: 20170628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Caliber Therapeutics, Inc. CENTRAL INDEX KEY: 0001710388 IRS NUMBER: 204508285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289571 FILM NUMBER: 17933344 BUSINESS ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 215 862 5797 MAIL ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 D 1 primary_doc.xml X0707 D LIVE 0001710388 Caliber Therapeutics, Inc. 150 UNION SQUARE DRIVE NEW HOPE PA PENNSYLVANIA 18938 215 862 5797 DELAWARE PFO Development, Inc. None Corporation true Darren Sherman 150 UNION SQUARE DRIVE New Hope PA PENNSYLVANIA 18938 Executive Officer Chief Executive Officer David Hochman 150 UNION SQUARE DRIVE New Hope PA PENNSYLVANIA 18938 Executive Officer Director Chairman of the Board of Directors Geoffrey Smith 150 UNION SQUARE DRIVE New Hope PA PENNSYLVANIA 18938 Director Other Health Care Decline to Disclose 06b false 2017-06-13 false true Units consisting of (i) an unsecured convertible promissory note and (ii) a warrant to purchase shares of Common Stock false 100000 Aegis Capital Corp. 15007 Aegis Capital Corp. 15007 810 7TH AVE New York NY NEW YORK 10019 All States false 7000000 200000 6800000 false 2 0 316280 true Amount of placement agent fees above reflects the maximum amount of fees payable pursuant to the offering if the maximum amount of Units is sold. 0 No proceeds are proposed to be used for payments to such persons other than ordinary salary expenses that may be paid out of working capital. false Caliber Therapeutics, Inc. Darren Sherman Darren Sherman Chief Executive Officer 2017-06-27